Richard Brian Collie, DO | |
510 Cherry St, Suite 205, Bluefield, WV 24701-3338 | |
(304) 324-2954 | |
(304) 324-2955 |
Full Name | Richard Brian Collie |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Location | 510 Cherry St, Bluefield, West Virginia |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1336256742 | NPI | - | NPPES |
0101252000 | Medicaid | WV |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | DO1630 (West Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Richard Brian Collie, DO 510 Cherry St, Suite 205, Bluefield, WV 24701-3338 Ph: (304) 324-2954 | Richard Brian Collie, DO 510 Cherry St, Suite 205, Bluefield, WV 24701-3338 Ph: (304) 324-2954 |
News Archive
Family Research Council praised the U.S. House of Representatives for today approving U.S. Rep. Mike Pence's (R-IN) amendment to prevent any funds made available under the continuing appropriation bill from being provided to Planned Parenthood. Pence and Family Research Council (FRC) President Tony Perkins co-authored an op-ed that ran today in The Daily Caller regarding this amendment.
Current standard imaging techniques for initial staging of prostate cancer often underestimate the extent of disease beyond the prostate.
When it comes to preventive care and confidential medical services, parents and their adolescent children actually agree with each other. They both believe that preventive care is important, that adolescents should be provided with opportunities to speak with their doctor one-on-one, and that some services should be confidential.
ThromboGenics NV, an integrated biopharmaceutical company focused on developing and commercializing innovative treatments for diabetic eye disease, today announces that the first patient has been enrolled in its Phase II CIRCLE study evaluating the efficacy and safety of multiple doses of ocriplasmin in inducing total posterior vitreous detachment (PVD) in patients with non-proliferative diabetic retinopathy (NPDR).
› Verified 7 days ago